InCVAX as a Novel In Situ Autologous Cancer Vaccine

Samuel Siu Kit Lam; FeiFan Zhou; Tomas Hode; Robert Nordquist; Lu Alleruzzo; Joe Raker; Wei R. Chen

doi:10.1364/ACPC.2015.ASu1I.2

Asia Communications and Photonics Conference 2015
OSA Technical Digest (online) (Optica Publishing Group, 2015),
paper ASu1I.2
•https://doi.org/10.1364/ACPC.2015.ASu1I.2

InCVAX as a Novel In Situ Autologous Cancer Vaccine

Samuel Siu Kit Lam, FeiFan Zhou, Tomas Hode, Robert Nordquist, Lu Alleruzzo, Joe Raker, and Wei R. Chen

Asia Communications and Photonics Conference 2015

Hong Kong Hong Kong
19–23 November 2015
ISBN: 978-1-943580-06-4

From the session
Therapeutics and In Vivo Imaging (ASu1I)

Not Accessible

Your library or personal account may give you access

Get PDF
Email
Share
Get Citation
Copy Citation Text
S. S. K. Lam, F. Zhou, T. Hode, R. Nordquist, L. Alleruzzo, J. Raker, and W. R. Chen, "InCVAX as a Novel In Situ Autologous Cancer Vaccine," in Asia Communications and Photonics Conference 2015, C. Lu, J. Luo, Y. Ji, K. Kitayama, H. Tam, K. Xu, P. Ghiggino, and N. Wada, eds., OSA Technical Digest (online) (Optica Publishing Group, 2015), paper ASu1I.2.

Export Citation
- BibTex
- Endnote (RIS)
- HTML
- Plain Text
Citation alert
Save article

Abstract

Immunophotonics is developing inCVAX, an in situ autologous cancer vaccine, which combines thermal laser with immunotherapy for the treatment of metastatic cancers. Promising results have emerged in the preclinical and early clinical studies.

PDF Article

More Like This

inCVAX - a biophotonics approach based cancer therapy

Wei R. Chen
ASu1I.1 Asia Communications and Photonics Conference (ACP) 2015

Immunophotonics-based therapy for metastatic cancers

Wei R. Chen
T1B.1 International Conference on Photonics and Imaging in Biology and Medicine (PIBM) 2017

Laser Immunotherapy for Cancer Treatment

Wei R. Chen
ATh3L.3 Asia Communications and Photonics Conference (ACP) 2013

Previous Article Next Article